News & Updates

Among pregnant women with early gestational diabetes or pre-existing type 2 diabetes (T2D), using metformin in addition to insulin neither lowers the likelihood of preterm pre-eclampsia nor improves serum biomarkers associated with cardiovascular disease risk, according to a study.

For atrial fibrillation (AF) patients with normal or impaired renal function, use of nonvitamin K antagonist oral anticoagulants (NOACs) results in improved outcomes relative to vitamin K antagonist (VKA) therapy, suggests a study presented at ESC 2024.

Postmenopausal women who use menopausal hormone therapy (MHT) appear to have increased Lactobacillus abundance and lower vaginal microbial community diversity, according to a study.

Postmenopausal women may benefit from laughter yoga, acupressure, and a mindfulness-based stress reduction program, all of which have been shown to alleviated menopause symptoms and improve quality of life in a study.

The novel oral corticotropin-releasing factor type 1 receptor antagonist crinecerfont helps supress androstenedione levels in children with congenital adrenal hyperplasia (CAH) and reduce the need for glucocorticoids, as shown in the phase III CAHtalyst Pediatric trial.

Using screens once already in bed appears to have a negative impact on sleep in young people, especially when screen time involves gaming or multitasking, according to a study.

Users of glucagon-like peptide-1 (GLP-1) receptor agonists, most of whom have type 2 diabetes, are not at increased risk of suicide death, self-harm, or incident depression and anxiety-related disorders, as shown in a study.